C57BL/6JCya-Rnaseh2bem1flox/Cya
Common Name:
Rnaseh2b-flox
Product ID:
S-CKO-13537
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Rnaseh2b-flox
Strain ID
CKOCMP-67153-Rnaseh2b-B6J-VA
Gene Name
Product ID
S-CKO-13537
Gene Alias
1110019N06Rik; 2610207P08Rik; Dleu8
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
14
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Rnaseh2bem1flox/Cya mice (Catalog S-CKO-13537) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000022499
NCBI RefSeq
NM_026001
Target Region
Exon 5
Size of Effective Region
~0.6 kb
Detailed Document
Overview of Gene Research
Rnaseh2b, a subunit of the RNase H2 endonuclease complex, plays a crucial role in ribonucleotide excision repair by cleaving RNA in RNA:DNA hybrids [2,5]. This function is essential for maintaining genomic stability, and its associated pathways are vital for normal cellular function. Genetic models, such as KO or CKO mouse models, are valuable tools for studying Rnaseh2b's function.
Mutations in Rnaseh2b are associated with Aicardi-Goutières syndrome, an inflammatory disorder [2,3,4,5,7]. In patients with this syndrome, there is an increase in type I interferon activity, and a subset of patients with Rnaseh2b mutations may have a less severe phenotype and lower mortality compared to those with mutations in other related genes [2,5]. In prostate cancer, loss of Rnaseh2b can sensitize tumor cells to PARP inhibition, but co-deletion of adjacent RB1 can override this sensitivity [1,6].
In conclusion, Rnaseh2b is essential for ribonucleotide excision repair and maintaining genomic stability. Studies using genetic models have revealed its role in diseases like Aicardi-Goutières syndrome and prostate cancer. Understanding Rnaseh2b's function provides insights into disease mechanisms and potential therapeutic strategies for these conditions.
References:
1. Carmichael, Juliet, Figueiredo, Ines, Gurel, Bora, Sharp, Adam, de Bono, Johann. 2024. RNASEH2B loss and PARP inhibition in advanced prostate cancer. In The Journal of clinical investigation, 134, . doi:10.1172/JCI178278. https://pubmed.ncbi.nlm.nih.gov/38833311/
2. Crow, Yanick J, Chase, Diana S, Lowenstein Schmidt, Johanna, Orcesi, Simona, Rice, Gillian I. 2015. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. In American journal of medical genetics. Part A, 167A, 296-312. doi:10.1002/ajmg.a.36887. https://pubmed.ncbi.nlm.nih.gov/25604658/
3. Rice, Gillian I, Forte, Gabriella M A, Szynkiewicz, Marcin, Lebon, Pierre, Crow, Yanick J. 2013. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. In The Lancet. Neurology, 12, 1159-69. doi:10.1016/S1474-4422(13)70258-8. https://pubmed.ncbi.nlm.nih.gov/24183309/
4. Liu, Anran, Ying, Songcheng. 2023. Aicardi-Goutières syndrome: A monogenic type I interferonopathy. In Scandinavian journal of immunology, 98, e13314. doi:10.1111/sji.13314. https://pubmed.ncbi.nlm.nih.gov/37515439/
5. Rice, Gillian, Patrick, Teresa, Parmar, Rekha, Lebon, Pierre, Crow, Yanick J. 2007. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. In American journal of human genetics, 81, 713-25. doi:. https://pubmed.ncbi.nlm.nih.gov/17846997/
6. Miao, Chenkui, Tsujino, Takuya, Takai, Tomoaki, Kibel, Adam S, Jia, Li. 2022. RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. In Science advances, 8, eabl9794. doi:10.1126/sciadv.abl9794. https://pubmed.ncbi.nlm.nih.gov/35179959/
7. Garau, Jessica, Masnada, Silvia, Dragoni, Francesca, Tonduti, Davide, Cereda, Cristina. 2021. Case Report: Novel Compound Heterozygous RNASEH2B Mutations Cause Aicardi-Goutières Syndrome. In Frontiers in immunology, 12, 672952. doi:10.3389/fimmu.2021.672952. https://pubmed.ncbi.nlm.nih.gov/33981319/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen